Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Cytotoxic Effect of Albendazole on the Breast Cancer and Melanoma Cell Lines

Sepideh Javdan 1 , Hashem Nayeri 1 , * and Golnaz Vaseghi 2
Authors Information
1 Department of Biochemistry, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
2 Applied Physiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: June 2018, 20 (6); e9100
  • Published Online: August 12, 2018
  • Article Type: Research Article
  • Received: September 23, 2016
  • Revised: March 13, 2018
  • Accepted: April 4, 2018
  • DOI: 10.5812/zjrms.9100

To Cite: Javdan S, Nayeri H, Vaseghi G . Cytotoxic Effect of Albendazole on the Breast Cancer and Melanoma Cell Lines, Zahedan J Res Med Sci. 2018 ; 20(6):e9100. doi: 10.5812/zjrms.9100.

Abstract
Copyright © 2018, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11-30. doi: 10.3322/caac.21166. [PubMed: 23335087].
  • 2. Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501(7467):328-37. doi: 10.1038/nature12624. [PubMed: 24048065]. [PubMed Central: PMC4521623].
  • 3. Fisher R, Pusztai L, Swanton C. Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer. 2013;108(3):479-85. doi: 10.1038/bjc.2012.581. [PubMed: 23299535]. [PubMed Central: PMC3593543].
  • 4. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999;80(6):827-41.
  • 5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57-70. [PubMed: 10647931].
  • 6. Teicher BA, Selwood DL, Andrews PA. Erratum: Anticancer drug development: preclinical screening, clinical trials and approval. British Journal of Cancer. 2004;91(11):1977. doi: 10.1038/sj.bjc.6602286.
  • 7. Gallucci BB. Selected concepts of cancer as a disease: from the Greeks to 1900. Oncol Nurs Forum. 1985;12(4):67-71. [PubMed: 3892501].
  • 8. Pourgholami MH, Yan Cai Z, Lu Y, Wang L, Morris DL. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice. Clin Cancer Res. 2006;12(6):1928-35. doi: 10.1158/1078-0432.CCR-05-1181. [PubMed: 16551879].
  • 9. Pourgholami MH, Wangoo KT, Morris DL. Albendazole-cyclodextrin complex: enhanced cytotoxicity in ovarian cancer cells. Anticancer Res. 2008;28(5A):2775-9. [PubMed: 19035309].
  • 10. Gupta RS. Cross-resistance of nocodazole-resistant mutants of CHO cells toward other microtubule inhibitors: similar mode of action of benzimidazole carbamate derivatives and NSC 181928 and TN-16. Mol Pharmacol. 1986;30(2):142-8. [PubMed: 3736539].
  • 11. Pourgholami MH, Akhter J, Wang L, Lu Y, Morris DL. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. Cancer Chemother Pharmacol. 2005;55(5):425-32. doi: 10.1007/s00280-004-0927-6. [PubMed: 15565325].
  • 12. Patel K, Doudican NA, Schiff PB, Orlow SJ. Albendazole sensitizes cancer cells to ionizing radiation. Radiat Oncol. 2011;6:160. doi: 10.1186/1748-717X-6-160. [PubMed: 22094106]. [PubMed Central: PMC3231941].
  • 13. Pourgholami MH, Woon L, Almajd R, Akhter J, Bowery P, Morris DL. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett. 2001;165(1):43-9. doi: 10.1016/s0304-3835(01)00382-2.
  • 14. Morris DL, Jourdan JL, Pourgholami MH. Pilot study of albendazole in patients with advanced malignancy. Effect on serum tumor markers/high incidence of neutropenia. Oncology. 2001;61(1):42-6. doi: 10.1159/000055351. [PubMed: 11474247].
  • 15. Alvarez LI, Sanchez SF, Lanusse CE. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep. J Vet Pharmacol Ther. 1999;22(2):77-86. [PubMed: 10372592].
  • 16. Kralova V, Hanusova V, Stankova P, Knoppova K, Canova K, Skalova L. Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines. Anticancer Drugs. 2013;24(9):911-9. doi: 10.1097/CAD.0b013e3283648c69. [PubMed: 23884106].
  • 17. Pourgholami MH, Szwajcer M, Chin M, Liauw W, Seef J, Galettis P, et al. Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer. Cancer Chemother Pharmacol. 2010;65(3):597-605. doi: 10.1007/s00280-009-1157-8. [PubMed: 19904538].
  • 18. Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70(2):440-6. doi: 10.1158/0008-5472.CAN-09-1947. [PubMed: 20068163].
  • 19. Ehteda A, Galettis P, Pillai K, Morris DL. Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice. BMC Cancer. 2013;13:86. doi: 10.1186/1471-2407-13-86. [PubMed: 23432760]. [PubMed Central: PMC3606618].
  • 20. Chu SW, Badar S, Morris DL, Pourgholami MH. Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole. Anticancer Res. 2009;29(10):3791-6. [PubMed: 19846910].
  • 21. Khalilzadeh A, Wangoo KT, Morris DL, Pourgholami MH. Epothilone-paclitaxel resistant leukemic cells CEM/dEpoB300 are sensitive to albendazole: Involvement of apoptotic pathways. Biochem Pharmacol. 2007;74(3):407-14. doi: 10.1016/j.bcp.2007.05.006. [PubMed: 17560963].
  • 22. Kummalue T. Molecular mechanism of herbs in human lung cancer cells. J Med Assoc Thai. 2005;88(11):1725-34. [PubMed: 16471127].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments